Stephen Lockhart

I am Vice President and Head of Europe and Asia-Pacific Vaccine Clinical Research and Development (VCRD) at Pfizer.

I qualified as a physician in 1980. Following training in hospital internal medicine and research, I joined the pharmaceutical industry in 1986. I have over 30 years of experience in pharmaceutical and vaccine development and have extensive experience building and leading teams responsible for strategic and operational aspects of the development, registration and post-marketing support of numerous products. My experience spans activities in Europe, North America, China, Japan, Australia, South Africa, Singapore and other markets around the world. My roles include senior positions in Vaccine Development at Lederle Praxis Biologicals, Wyeth Vaccine Research, Emergent Biosolutions, Sanofi Pasteur MSD and Pfizer. I have worked on the development of vaccines against influenza, varicella, respiratory syncytial virus, H. Influenza type b, anthrax, tuberculosis, pneumococcus, meningococcus, Clostridium difficile, Staphylococcus aureus, tick borne encephalitis (TBE) and typhoid as well as paediatric combination vaccines.

I currently lead clinical activities on a phase3 Clostridium difficile vaccine, a TBE vaccine extension to new countries and preclinical E. coli and influenza RNA vaccines